Wednesday, February 1, 2012

Reason for Hope?

The first drug that treats an underlying cause of cystic fibrosis, rather than just the symptoms, was approved by the Food and Drug Administration on Tuesday, January 31, 2012.

Posted by at

1 comment:

James R said...

Tom and Mary confirm the amazing fact that John is one of the 4% who have the G551D mutation. Joyous news!

February 3, 2012 at 3:03 PM

Post a Comment

Subscribe to: Post Comments (Atom)